Skip to main content

Table 2 Reasons for declining

From: Participants’ characteristics and motivations to screen for HIV vaccine and monoclonal antibody trials in KwaZulu-Natal, South Africa

 

Stratified by HVTN trials

 
 

100s

100/111/108

702

703/HPTN081

Sig.

n

37

160

42

 

Reason not enrolled, n (%)

   

NA

Social pressure to not participate

1 (2.7)

2 (1.2)

0 (0.0)

 

Unwilling to receive study product

0 (0.0)

0 (0.0)

0 (0.0)

 

Individual changes his/her mind

6 (16.2)

56 (35)

15 (35.7)

 

Unable to contact/no show

28 (75.7)

58 (36.2)

11 (26.2)

 

Unable to comply with visit schedule

2 (5.4)

28 (17.5)

8 (19)

 

Unwilling to risk testing positive on HIV test due to vaccine-induced seropositivity

0 (0.0)

1 (0.6)

0 (0.0)

 

Unwilling to have IV infusion

0 (0.0)

0 (0.0)

0 (0.0)

 

Other

0 (0.0)

15 (9.4)

8 (19)